Form 4: BioLargo Director Dennis E. Marshall Acquires Options in Lieu of Fees
SEC Form 4 Filing
Director Dennis E. Marshall receives options for BioLargo shares as compensation for board service fees.
Summary
- On December 31, 2024, BioLargo director Dennis E. Marshall received an option to purchase 98,684 shares of common stock at an exercise price of $0.19.
- The options were granted as payment for $18,750 in board service fees for the most recent quarterly period.
- These options were issued under the company's 2024 Equity Incentive Plan and expire on December 31, 2034.
- Following this transaction, Marshall directly owns 4,624,625 shares of BioLargo.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The director is receiving options, which aligns interests with shareholders. There are no explicit negative indicators.
Positives
- The issuance of options as compensation conserves the company's cash reserves.
- The director's increased stake in the company aligns his interests with those of shareholders.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance.
Industry Context
The use of equity-based compensation is a common practice in publicly traded companies to align the interests of directors and management with those of shareholders. This encourages long-term value creation.
Comparison to Industry Standards
- Many small-cap companies use stock options as part of their compensation packages for directors and executives.
- The specific terms of the option grant, such as the exercise price and vesting schedule, are generally determined based on industry benchmarks and the company's specific circumstances.
- Comparable companies in the cleantech or environmental technology sectors also utilize equity compensation to attract and retain talent.
Related Party Transactions
- The grant of options to Dennis E. Marshall, a director, is a related party transaction that is disclosed in the filing.
Stakeholder Impact
- Shareholders may view the option grant positively as it aligns the director's interests with the company's long-term success.
- Employees may see this as a sign of the company's commitment to rewarding its leadership.
Key Dates
| Date | Description |
|---|---|
| February 14, 2017 | Date of Limited Power of Attorney for Section 16 Reporting Obligations. |
| December 31, 2024 | Date of transaction: Dennis E. Marshall acquired options to purchase common stock. |
| December 31, 2024 | Options become exercisable. |
| December 31, 2034 | Expiration date of the options. |
| January 03, 2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.